Role of the vagus nerve in the development and treatment of diet-induced obesity

Journal of Physiology

Volumn 594, Issue 20, 2016, Pages 5791-5815

  de Lartigue, Guillaume ^a,b  

^a JOHN B PIERCE LABORATORY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE PLUS NALTREXONE; HEMOGLOBIN A1C; LIRAGLUTIDE; PROTEIN C FOS; RIMONABANT; SITAGLIPTIN; TETRAHYDROLIPSTATIN; VILDAGLIPTIN;

ACTION POTENTIAL; ALTERNATING CURRENT; BLOATING; DEPRESSION; DIET INDUCED OBESITY; DOPAMINE RELEASE; DYSPHAGIA; ELECTROPHYSIOLOGY; ENERGY EXPENDITURE; EPILEPSY; FOOD INTAKE; GASTROINTESTINAL TRACT; GLYCEMIC CONTROL; HEARTBURN; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERPHAGIA; LIPID DIET; METABOLIC REGULATION; MUSCLE CRAMP; MYENTERIC PLEXUS; NAUSEA; NEGATIVE FEEDBACK; NERVE BLOCK; NERVE CELL PLASTICITY; NERVE FUNCTION; NERVE STIMULATION; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; NUTRIENT AVAILABILITY; NUTRITIONAL STATUS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STOMACH DISTENSION; STOMACH MOTILITY; STOMACH SECRETION; TRANSCRIPTION REGULATION; VAGUS NERVE; WEIGHT CONTROL; WEIGHT REDUCTION;

EID: 84991246758     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271538     Document Type: Review

References (181)

1. Al Massadi O, Pardo M, Roca-Rivada A, Castelao C, Casanueva FF & Seoane LM (2010). Macronutrients act directly on the stomach to regulate gastric ghrelin release. J Endocrinol Invest 33, 599–602.
2. Appleyard SM, Bailey TW, Doyle MW, Jin YH, Smart JL, Low MJ & Andresen MC (2005). Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J Neurosci 25, 3578–3585.
3. Barrera JG, Jones KR, Herman JP, D'Alessio DA, Woods SC & Seeley RJ (2011). Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. J Neurosci 31, 3904–3913.
4. Berridge KC (1996). Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20, 1–25.
5. Berthoud HR (2008a). Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20 Suppl 1, 64–72.
6. Berthoud HR (2008b). The vagus nerve, food intake and obesity. Regul Pept 149, 15–25.
7. Berthoud HR (2011). Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol 21, 888–896.
8. Berthoud HR, Carlson NR & Powley TL (1991). Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol Regul Integr Comp Physiol 260, R200–R207.
9. Berthoud HR, Kressel M & Neuhuber WL (1992). An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat Embryol 186, 431–442.
10. Berthoud HR, Kressel M, Raybould HE & Neuhuber WL (1995). Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol 191, 203–212.
11. Berthoud HR & Neuhuber WL (2000). Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85, 1–17.
12. Berthoud HR & Patterson LM (1996). Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat (Basel) 156, 123–131.
13. Bhadra N & Kilgore KL (2005). High-frequency electrical conduction block of mammalian peripheral motor nerve. Muscle Nerve 32, 782–790.
14. Biraben A, Guerin S, Bobillier E, Val-Laillet D & Malbert CH (2008). Central activation after chronic vagus nerve stimulation in pigs. Contibution of functional imaging. Bull Acad Vet Fr 161, 441–448.
15. Bodenlos JS, Kose S, Borckardt JJ, Nahas Z, Shaw D, O'Neil PM, Pagoto SL & George MS (2007a). Vagus nerve stimulation and emotional responses to food among depressed patients. J Diabetes Sci Technol 1, 771–779.
16. Bodenlos JS, Kose S, Borckardt JJ, Nahas Z, Shaw D, O'Neil PM & George MS (2007b). Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite 48, 145–153.
17. Bohorquez DV, Shahid RA, Erdmann A, Kreger AM, Wang Y, Calakos N, Wang F & Liddle RA (2015). Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest 125, 782–786.
18. Borckardt JJ, Kozel FA, Anderson B, Walker A & George MS (2005). Vagus nerve stimulation affects pain perception in depressed adults. Pain Res Manag 10, 9–14.
19. Browning KN, Babic T, Holmes GM, Swartz E & Travagli RA (2013a). A critical re-evaluation of the specificity of action of perivagal capsaicin. J Physiol 591, 1563–1580.
20. Browning KN, Fortna SR & Hajnal A (2013b). Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol 591, 2357–2372.
21. Browning KN & Travagli RA (2011). Plasticity of vagal brainstem circuits in the control of gastrointestinal function. Auton Neurosci 161, 6–13.
22. Bugajski AJ, Gil K, Ziomber A, Zurowski D, Zaraska W & Thor PJ (2007). Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol 58 Suppl 1, 5–12.
23. Bugnard L & Hill AV (1935). Electric excitation of the fin nerve of sepia. J Physiol 83, 425–438.
24. Burdyga G, de Lartigue G, Raybould HE, Morris R, Dimaline R, Varro A, Thompson DG & Dockray GJ (2008). Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J Neurosci 28, 11583–11592.
25. Burdyga G, Varro A, Dimaline R, Thompson DG & Dockray GJ (2006a). Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones. Neuroscience 137, 1405–1415.
26. Burdyga G, Varro A, Dimaline R, Thompson DG & Dockray GJ (2006b). Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol 290, G1289–G1297.
27. Burdyga G, Varro A, Dimaline R, Thompson DG & Dockray GJ (2010). Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am J Physiol Gastrointest Liver Physiol 299, G63–G69.
28. Burneo JG, Faught E, Knowlton R, Morawetz R & Kuzniecky R (2002). Weight loss associated with vagus nerve stimulation. Neurology 59, 463–464.
29. Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR & Moody FG (2009). Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis 5, 224–229; discussion 229–230.
30. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR & Anvari M (2008). Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 143, 723–731.
31. Cammisotto P & Bendayan M (2012). A review on gastric leptin: the exocrine secretion of a gastric hormone. Anat Cell Biol 45, 1–16.
32. Cattell M & Gerard RW (1935). The "inhibitory" effect of high-frequency stimulation and the excitation state of nerve. J Physiol 83, 407–415.
33. Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE & George MS (2003). A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 37, 443–455.
34. Chung SA, Greenberg GR & Diamant NE (1992). Relationship of postprandial motilin, gastrin, and pancreatic polypeptide release to intestinal motility during vagal interruption. Can J Physiol Pharmacol 70, 1148–1153.
35. Clarke GD & Davison JS (1978). Mucosal receptors in the gastric antrum and small intestine of the rat with afferent fibres in the cervical vagus. J Physiol 284, 55–67.
36. Cohen ML & Georgievskaya Z (2011). Histopathology of the stimulated vagus nerve: primum non nocere. Heart Fail Rev 16, 163–169.
37. Coll AP & Yeo GS (2013). The hypothalamus and metabolism: integrating signals to control energy and glucose homeostasis. Curr Opin Pharmacol 13, 970–976.
38. Covasa M, Grahn J & Ritter RC (2000a). High fat maintenance diet attenuates hindbrain neuronal response to CCK. Regul Pept 86, 83–88.
39. Covasa M, Grahn J & Ritter RC (2000b). Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet. Auton Neurosci 84, 8–18.
40. Covasa M & Ritter RC (1998). Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 19, 1407–1415.
41. Covasa M & Ritter RC (2000). Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol Regul Integr Comp Physiol 278, R166–R170.
42. Covasa M & Ritter RC (2001). Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22, 1339–1348.
43. Daly DM, Park SJ, Valinsky WC & Beyak MJ (2011). Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 589, 2857–2870.
44. Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjoth TV, Andreasen AH, Jensen CB & DeFronzo RA (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA 314, 687–699.
45. Dedeurwaerdere S, Cornelissen B, Van Laere K, Vonck K, Achten E, Slegers G & Boon P (2005). Small animal positron emission tomography during vagus nerve stimulation in rats: a pilot study. Epilepsy Res 67, 133–141.
46. de Lartigue G (2014). Putative roles of neuropeptides in vagal afferent signaling. Physiol Behav 136, 155–169.
47. de Lartigue G, Barbier de la Serre C, Espero E, Lee J & Raybould HE (2011). Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 301, E187–E195.
48. de Lartigue G, Barbier de la Serre C, Espero E, Lee J & Raybould HE (2012). Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One 7, e32967.
49. de Lartigue G, Dimaline R, Varro A & Dockray GJ (2007). Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci 27, 2876–2882.
50. De Lartigue G, Dimaline R, Varro A, Raybould H, De la Serre CB & Dockray GJ (2010a). Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons. Gastroenterology 138, 1479–1490.
51. de Lartigue G, Lur G, Dimaline R, Varro A, Raybould H & Dockray GJ (2010b). EGR1 is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. Endocrinology 151, 3589–3599.
52. de Lartigue G, Ronveaux CC & Raybould HE (2014a). Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. Mol Metab 3, 595–607.
53. de Lartigue G, Ronveaux CC & Raybould HE (2014b). Vagal plasticity the key to obesity. Mol Metab 3, 855–856.
54. de La Serre CB, de Lartigue G & Raybould HE (2015). Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav 139, 188–194.
55. Deloose E, Janssen P, Depoortere I & Tack J (2012). The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol 9, 271–285.
56. Dockray GJ (2009). Cholecystokinin and gut-brain signalling. Regul Pept 155, 6–10.
57. Dockray GJ & Burdyga G (2011). Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance. Acta Physiol (Oxf) 201, 313–321.
58. Duca FA, Swartz TD, Sakar Y & Covasa M (2012). Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 7, e39748.
59. Duca FA, Swartz TD, Sakar Y & Covasa M (2013a). Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors. Int J Obes (Lond) 37, 375–381.
60. Duca FA, Zhong L & Covasa M (2013b). Reduced CCK signaling in obese-prone rats fed a high fat diet. Horm Behav 64, 812–817.
61. Foldes EL, Ackermann DM, Bhadra N, Kilgore KL & Bhadra N (2011). Design, fabrication and evaluation of a conforming circumpolar peripheral nerve cuff electrode for acute experimental use. J Neurosci Methods 196, 31–37.
62. Fox EA (2013). Vagal afferent controls of feeding: a possible role for gastrointestinal BDNF. Clin Auton Res 23, 15–31.
63. Frank S, Veit R, Sauer H, Enck P, Friederich HC, Unholzer T, Bauer UM, Linder K, Heni M, Fritsche A & Preissl H (2015). Dopamine depletion reduces food-related reward activity independent of BMI. Neuropsychopharmacology, 41, 1551–1559.
64. Fuhrer D, Zysset S & Stumvoll M (2008). Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. Obesity (Silver Spring) 16, 945–950.
65. Gibson EL & Mohiyeddini C (2008). Vagus nerve stimulation confuses appetite: comment on Bodenlos et al (2007). Appetite 51, 223–225; discussion 226–230.
66. Gil K, Bugajski A, Kurnik M & Thor P (2012). Chronic vagus nerve stimulation reduces body fat, blood cholesterol and triglyceride levels in rats fed a high-fat diet. Folia Med Cracov 52, 79–96.
67. Gil K, Bugajski A, Kurnik M & Thor P (2013). Electrical chronic vagus nerve stimulation activates the hypothalamic-pituitary-adrenal axis in rats fed high-fat diet. Neuro Endocrinol Lett 34, 314–321.
68. Gil K, Bugajski A, Kurnik M, Zaraska W & Thor P (2009). Physiological and morphological effects of long-term vagal stimulation in diet induced obesity in rats. J Physiol Pharmacol 60 Suppl 3, 61–66.
69. Gil K, Bugajski A, Skowron B & Thor P (2011a). Increased c-Fos expression in nodose ganglion in rats with electrical vagus nerve stimulation. Folia Med Cracov 51, 45–58.
70. Gil K, Bugajski A & Thor P (2011b). Electrical vagus nerve stimulation decreases food consumption and weight gain in rats fed a high-fat diet. J Physiol Pharmacol 62, 637–646.
71. Gortz L, Bjorkman AC, Andersson H & Kral JG (1990). Truncal vagotomy reduces food and liquid intake in man. Physiol Behav 48, 779–781.
72. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R & Nawaz H (2003). Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 26, 1064–1068.
73. Grill HJ & Norgren R (1978). The taste reactivity test. II. Mimetic responses to gustatory stimuli in chronic thalamic and chronic decerebrate rats. Brain Res 143, 281–297.
74. Gubitosi-Klug RA (2014). The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care 37, 44–49.
75. Hall KE, el-Sharkawy TY & Diamant NE (1986). Vagal control of canine postprandial upper gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol 250, G501–G510.
76. Han L, Jian-Bin Z, Chen X, Qing-Qing T, Wei-Xing S, Jing-Zhu Z, Jian-De C & Yin-Ping W (2015). Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet-induced obese rats. Nutrition 31, 1416–1422.
77. Hayes MR, Skibicka KP & Grill HJ (2008). Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149, 4059–4068.
78. Henry TR, Bakay RA, Votaw JR, Pennell PB, Epstein CM, Faber TL, Grafton ST & Hoffman JM (1998). Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39, 983–990.
79. Holland PC, Petrovich GD & Gallagher M (2002). The effects of amygdala lesions on conditioned stimulus-potentiated eating in rats. Physiol Behav 76, 117–129.
80. Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, Morton JM, Leslie DB, Brancatisano R, Kow L, O'Rourke RW, Deveney C, Takata M, Miller CJ, Knudson MB, Tweden KS, Shikora SA, Sarr MG & Billington CJ (2014). Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA 312, 915–922.
81. Joseph L & Butera RJ (2011). High-frequency stimulation selectively blocks different types of fibers in frog sciatic nerve. IEEE Trans Neural Syst Rehabil Eng 19, 550–557.
82. Joyner K, Smith GP & Gibbs J (1993). Abdominal vagotomy decreases the satiating potency of CCK-8 in sham and real feeding. Am J Physiol Regul Integr Comp Physiol 264, R912–R916.
83. Kang JG & Park CY (2012). Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J 36, 13–25.
84. Kentish S, Li H, Philp LK, O'Donnell TA, Isaacs NJ, Young RL, Wittert GA, Blackshaw LA & Page AJ (2012). Diet-induced adaptation of vagal afferent function. J Physiol 590, 209–221.
85. Kentish SJ, O'Donnell TA, Frisby CL, Li H, Wittert GA & Page AJ (2014). Altered gastric vagal mechanosensitivity in diet-induced obesity persists on return to normal chow and is accompanied by increased food intake. Int J Obes (Lond) 38, 636–642.
86. Kentish SJ, O'Donnell TA, Isaacs NJ, Young RL, Li H, Harrington AM, Brierley SM, Wittert GA, Blackshaw LA & Page AJ (2013). Gastric vagal afferent modulation by leptin is influenced by food intake status. J Physiol 591, 1921–1934.
87. Kentish SJ & Page AJ (2014). Plasticity of gastro-intestinal vagal afferent endings. Physiol Behav 136, 170–178.
88. Kilgore KL & Bhadra N (2014). Reversible nerve conduction block using kilohertz frequency alternating current. Neuromodulation 17, 242–254; discussion 254-245.
89. King P, Peacock I & Donnelly R (1999). The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 48, 643–648.
90. 15O blood flow imaging. Neurosurgery 39, 426–430; discussion 430-421.
91. Konturek SJ, Konturek JW, Pawlik T & Brzozowski T (2004). Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55, 137–154.
92. Koren MS & Holmes MD (2006). Vagus nerve stimulation does not lead to significant changes in body weight in patients with epilepsy. Epilepsy Behav 8, 246–249.
93. Kral JG (1978). Vagotomy for treatment of severe obesity. Lancet 1, 307–308.
94. Kral JG (1979). Vagotomy as a treatment for morbid obesity. Surg Clin North Am 59, 1131–1138.
95. Kral JG (1980). Effects of truncal vagotomy on body weight and hyperinsulinemia in morbid obesity. Am J Clin Nutr 33, 416–419.
96. Kral JG (1989). Surgical treatment of obesity. Med Clin North Am 73, 251–264.
97. Kral JG & Gortz L (1981). Truncal vagotomy in morbid obesity. Int J Obes 5, 431–435.
98. Krieger JP, Arnold M, Pettersen KG, Lossel P, Langhans W & Lee SJ (2016). Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia. Diabetes 65, 34–43.
99. Krolczyk G, Laskiewicz J, Sobocki J, Matyja A, Kolasinska-Kloch W & Thor PJ (2005). The effects of baclofen on the feeding behaviour and body weight of vagally stimulated rats. J Physiol Pharmacol 56, 121–131.
100. Krolczyk G, Zurowski D, Sobocki J, Slowiaczek MP, Laskiewicz J, Matyja A, Zaraska K, Zaraska W & Thor PJ (2001). Effects of continuous microchip (MC) vagal neuromodulation on gastrointestinal function in rats. J Physiol Pharmacol 52, 705–715.
101. Lal S, Kirkup AJ, Brunsden AM, Thompson DG & Grundy D (2001). Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol 281, G907–G915.
102. Lambert JM & Chari RV (2014). Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. J Med Chem 57, 6949–6964.
103. Laskiewicz J, Krolczyk G, Zurowski G, Sobocki J, Matyja A & Thor PJ (2003). Effects of vagal neuromodulation and vagotomy on control of food intake and body weight in rats. J Physiol Pharmacol 54, 603–610.
104. Le Sauter J, Goldberg B & Geary N (1988). CCK inhibits real and sham feeding in gastric vagotomized rats. Physiol Behav 44, 527–534.
105. Li H, Kentish SJ, Kritas S, Young RL, Isaacs NJ, O'Donnell TA, Blackshaw LA, Wittert GA & Page AJ (2013). Modulation of murine gastric vagal afferent mechanosensitivity by neuropeptide W. Acta Physiol (Oxf) 209, 179–191.
106. MacLean DB (1985). Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat. Regul Pept 11, 321–333.
107. Maniscalco JW & Rinaman L (2013). Overnight food deprivation markedly attenuates hindbrain noradrenergic, glucagon-like peptide-1, and hypothalamic neural responses to exogenous cholecystokinin in male rats. Physiol Behav 121, 35–42.
108. Masuda M, Tomita H, Okubo K & Miyasaka K (1994). Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin. J Auton Nerv Syst 50, 131–138.
109. Mansuy-Aubert V, Gautron L, Lee S, Bookout AL, Kusminski C, Sun K, Zhang Y, Scherer PE, Mangelsdorf DJ & Elmquist JK (2015). Loss of the liver X receptor LXRalpha/beta in peripheral sensory neurons modifies energy expenditure. eLife 4 doi: 10.7554/eLife.06667.
110. Mathis C, Moran TH & Schwartz GJ (1998). Load-sensitive rat gastric vagal afferents encode volume but not gastric nutrients. Am J Physiol Regul Integr Comp Physiol 274, R280–R286.
111. Matyja A, Thor PJ, Sobocki J, Laskiewicz J, Kekus J, Tuz R, Koczanowski J & Zaraska W (2004). Effects of vagal pacing on food intake and body mass in pigs. Folia Med Cracov 45, 55–62.
112. Menon V & Uddin LQ (2010). Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214, 655–667.
113. Michl T, Jocic M, Heinemann A, Schuligoi R & Holzer P (2001). Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 92, 19–27.
114. Mobbs O, Crepin C, Thiery C, Golay A & Van der Linden M (2010). Obesity and the four facets of impulsivity. Patient Educ Couns 79, 372–377.
115. Monnikes H, Lauer G & Arnold R (1997). Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770, 277–288.
116. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, Marin JL, Delgado S, Casamitjana R & Vidal J (2006). Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91, 1735–1740.
117. Myronovych A, Kirby M, Ryan KK, Zhang W, Jha P, Setchell KD, Dexheimer PJ, Aronow B, Seeley RJ & Kohli R (2014). Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity (Silver Spring) 22, 390–400.
118. Naples GG, Mortimer JT, Scheiner A & Sweeney JD (1988). A spiral nerve cuff electrode for peripheral nerve stimulation. IEEE Trans Biomed Eng 35, 905–916.
119. Niijima A (1982). Glucose-sensitive afferent nerve-fibers in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 332, 315–323.
120. Niijima A (2000). Reflex effects of oral, gastrointestinal and hepatoportal glutamate sensors on vagal nerve activity. J Nutr 130, 971s–973s.
121. Norgren R & Smith GP (1988). Central distribution of subdiaphragmatic vagal branches in the rat. J Comp Neurol 273, 207–223.
122. Norgren R & Smith GP (1994). A method for selective section of vagal afferent or efferent axons in the rat. Am J Physiol Regul Integr Comp Physiol 267, R1136–R1141.
123. Ogbonnaya S & Kaliaperumal C (2013). Vagal nerve stimulator: Evolving trends. J Nat Sci Biol Med 4, 8–13.
124. O'Reardon JP, Cristancho P & Peshek AD (2006). Vagus nerve stimulation (VNS) and treatment of depression: to the brainstem and beyond. Psychiatry 3, 54–63.
125. Osharina V, Bagaev V, Wallois F & Larnicol N (2006). Autonomic response and Fos expression in the NTS following intermittent vagal stimulation: importance of pulse frequency. Auton Neurosci 126–127, 72–80.
126. Page AJ, Martin CM & Blackshaw LA (2002). Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol 87, 2095–2103.
127. Pardo JV, Sheikh SA, Kuskowski MA, Surerus-Johnson C, Hagen MC, Lee JT, Rittberg BR & Adson DE (2007). Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond) 31, 1756–1759.
128. Petrovich GD, Setlow B, Holland PC & Gallagher M (2002). Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating. J Neurosci 22, 8748–8753.
129. Phillips RJ & Powley TL (1996). Gastric volume rather than nutrient content inhibits food intake. Am J Physiol Regul Integr Comp Physiol 271, R766–R769.
130. Porubská K, Veit R, Preissl H, Fritsche A & Birbaumer N (2006). Subjective feeling of appetite modulates brain activity: an fMRI study. Neuroimage 32, 1273–1280.
131. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH & Livingston EH (2014). Long-term follow-up after bariatric surgery: a systematic review. JAMA 312, 934–942.
132. Raybould HE (2010). Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 153, 41–46.
133. Raybould HE & Tache Y (1988). Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol Gastrointest Liver Physiol 255, G242–G246.
134. Rehfeld JF (2014). Gastrointestinal hormones and their targets. Adv Exp Med Biol 817, 157–175.
135. Reyt S, Picq C, Sinniger V, Clarencon D, Bonaz B & David O (2010). Dynamic Causal Modelling and physiological confounds: a functional MRI study of vagus nerve stimulation. Neuroimage 52, 1456–1464.
136. Rinaman L, Baker EA, Hoffman GE, Stricker EM & Verbalis JG (1998). Medullary c-Fos activation in rats after ingestion of a satiating meal. Am J Physiol Regul Integr Comp Physiol 275, R262–R268.
137. Ripken D, van der Wielen N, van der Meulen J, Schuurman T, Witkamp RF, Hendriks HF & Koopmans SJ (2015). Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy. Physiol Behav 139, 167–176.
138. Ritter RC (2004). Gastrointestinal mechanisms of satiation for food. Physiol Behav 81, 249–273.
139. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C & Piomelli D (2001). An anorexic lipid mediator regulated by feeding. Nature 414, 209–212.
140. Rogers RC, McTigue DM & Hermann GE (1995). Vagovagal reflex control of digestion: afferent modulation by neural and “endoneurocrine” factors. Am J Physiol Gastrointest Liver Physiol 268, G1–G10.
141. Roslin M & Kurian M (2001). The Use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav 2, S11–S16.
142. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M & Barry JJ (2005). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 58, 355–363.
143. Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O'Rourke RW, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R & Group ES (2012). The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg 22, 1771–1782.
144. Savastano DM & Covasa M (2005). Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr 135, 1953–1959.
145. Schemann M (2005). Control of gastrointestinal motility by the “gut brain”–the enteric nervous system. J Pediatr Gastroenterol Nutr 41 Suppl 1, S4–S6.
146. Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, Cuomo V & Piomelli D (2008). The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8, 281–288.
147. Schwartz GJ, McHugh PR & Moran TH (1991). Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. Am J Physiol Regul Integr Comp Physiol 261, R64–R69.
148. Schwartz GJ & Moran TH (1998). Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am J Physiol Regul Integr Comp Physiol 274, R1236–R1242.
149. Shah A, Carreno FR & Frazer A (2014). Therapeutic modalities for treatment resistant depression: focus on vagal nerve stimulation and ketamine. Clin Psychopharmacol Neurosci 12, 83–93.
150. Shapiro RE & Miselis RR (1985). The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 238, 473–488.
151. Shikora SA, Toouli J, Herrera MF, Kulseng B, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB & Billingto CJ (2015a). Intermittent vagal nerve block for improvements in obesity, cardiovascular risk factors, and glycemic control in patients with type 2 diabetes mellitus: 2-year results of the VBLOC DM2 study. Obes Surg, doi: 10.1007/s11695-015-1914-1
152. Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB & Billington CJ (2013). Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes 2013, 245683.
153. Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD, Ikramuddin S, Miller CJ, Knudson MB, Tweden KS, Sarr MG & Billington CJ (2015b). Sustained weight loss with vagal nerve blockade but not with sham: 18-month results of the ReCharge trial. J Obes 2015, 365604.
154. Skak-Nielsen T, Holst JJ & Nielsen OV (1988). Role of gastrin-releasing peptide in the neural control of pepsinogen secretion from the pig stomach. Gastroenterology 95, 1216–1220.
155. Sobocki J, Fourtanier G, Estany J & Otal P (2006). Does vagal nerve stimulation affect body composition and metabolism? Experimental study of a new potential technique in bariatric surgery. Surgery 139, 209–216.
156. Sobocki J, Thor P, Krolczyk G, Uson J, Diaz-Guemes I & Lipinski M (2002). The cybergut. An experimental study on permanent microchip neuromodulation for control of gut function. Acta Chir Belg 102, 68–70.
157. Sobocki J, Thor PJ, Uson J, Diaz-Guemes I, Lipinski M, Calles C & Pascual S (2001). Microchip vagal pacing reduces food intake and body mass. Hepatogastroenterology 48, 1783–1787.
158. Suzuki K, Jayasena CN & Bloom SR (2012). Obesity and appetite control. Exp Diabetes Res 2012, 824305.
159. Swartz TD, Savastano DM & Covasa M (2010). Reduced sensitivity to cholecystokinin in male rats fed a high-fat diet is reversible. J Nutr 140, 1698–1703.
160. Takahashi T & Owyang C (1997). Characterization of vagal pathways mediating gastric accommodation reflex in rats. J Physiol 504, 479–488.
161. Teff KL (2008). Visceral nerves: vagal and sympathetic innervation. JPEN J Parenter Enteral Nutr 32, 569–571.
162. Tellez LA, Medina S, Han W, Ferreira JG, Licona-Limon P, Ren X, Lam TT, Schwartz GJ & de Araujo IE (2013). A gut lipid messenger links excess dietary fat to dopamine deficiency. Science 341, 800–802.
163. Torii K & Niijima A (2001). Effect of lysine on afferent activity of the hepatic branch of the vagus nerve in normal and L-lysine-deficient rats. Physiol Behav 72, 685–690.
164. Tweden KS, Anvari M, Bierk MD, Billington CJ, Camilleri M, Honda CN, Knudson MB, Larson DE, Wilson RR & Freston JW (2006a). Vagal blocking for obesity control (VBLOC): concordance of effects of very high frequency vagal blocking currents at the neural and organ levels using two pre-clinical models. Gastroenterology 130, A-148.
165. Tweden KS, Sarr MG, Bierk MD, Camilleri M, Kendrick ML, Knudson MB, Moody FG, Wilson RR & Anvari M (2006b). Vagal blocking for obesity control (VBLOC): Studies of pancreatic and gastric function and safety in a porcine model. Surg Obes Relat Dis 2, 301–302.
166. Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, Alonso-Alonso M, Audette M, Malbert CH & Stice E (2015). Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin 8, 1–31.
167. Val-Laillet D, Biraben A, Randuineau G & Malbert CH (2010). Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs. Appetite 55, 245–252.
168. van Kooten MJ, Veldhuizen MG, de Araujo IE, O'Malley SS & Small DM (2016). Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers. Physiol Behav 155, 131–140.
169. Vijgen GH, Bouvy ND, Leenen L, Rijkers K, Cornips E, Majoie M, Brans B & van Marken Lichtenbelt WD (2013). Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS One 8, e77221.
170. Waataja JJ, Tweden KS & Honda CN (2011). Effects of high-frequency alternating current on axonal conduction through the vagus nerve. J Neural Eng 8, 056013.
171. Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, Kumanyika S, Schmitz KH, Diewald LK, Barg R, Chittams J & Moore RH (2011). A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 365, 1969–1979.
172. Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, Zhu W, Wong CT, Thanos PK, Geliebter A, Biegon A & Fowler JS (2009). Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci USA 106, 1249–1254.
173. Williams DL, Baskin DG & Schwartz MW (2009). Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 150, 1680–1687.
174. Willing AE & Berthoud HR (1997). Gastric distension-induced c-fos expression in catecholaminergic neurons of rat dorsal vagal complex. Am J Physiol Regul Integr Comp Physiol 272, R59–R67.
175. Woodbury DM & Woodbury JW (1990). Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia 31 Suppl 2, S7–S19.
176. Yanovski SZ & Yanovski JA (2014). Long-term drug treatment for obesity: a systematic and clinical review. JAMA 311, 74–86.
177. Yi CX, la Fleur SE, Fliers E & Kalsbeek A (2010). The role of the autonomic nervous liver innervation in the control of energy metabolism. Biochim Biophys Acta 1802, 416–431.
178. Yuan H & Silberstein SD (2015). Vagus nerve and vagus nerve stimulation, a comprehensive review: Part II. Headache 56, 259–266.
179. Zagorodnyuk VP, Chen BN & Brookes SJ (2001). Intraganglionic laminar endings are mechano-transduction sites of vagal tension receptors in the guinea-pig stomach. J Physiol 534, 255–268.
180. Zhan C, Zhou J, Feng Q, Zhang JE, Lin S, Bao J, Wu P & Luo M (2013). Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J Neurosci 33, 3624–3632.
181. Ziomber A, Juszczak K, Kaszuba-Zwoinska J, Machowska A, Zaraska K, Gil K & Thor P (2009). Magnetically induced vagus nerve stimulation and feeding behavior in rats. J Physiol Pharmacol 60, 71–77.